Randomized Controlled Trial for Gefitinib (ZD1839)-coated Mechanism vs . Ordinary Device Angioplasty throughout Structural Hemodialysis General Accessibility: 12-month Result from your Nonsponsored Test
https://www.selleckchem.com/products/kpt-330.html